Gitlitz, B. J., Tsao-Wei, D. D., Groshen, S., Davies, A., Koczywas, M., Belani, C. P., . . . Gandara, D. R. (2012). A phase II study of halichondrin B analogue eribulin mesylate (E7389) in patients with advanced non-small cell lung cancer previously treated with a taxane: A California Cancer Consortium trial.
استشهاد بنمط شيكاغوGitlitz, Barbara J., et al. A Phase II Study of Halichondrin B Analogue Eribulin Mesylate (E7389) in Patients With Advanced Non-small Cell Lung Cancer Previously Treated With a Taxane: A California Cancer Consortium Trial. 2012.
MLA استشهادGitlitz, Barbara J., et al. A Phase II Study of Halichondrin B Analogue Eribulin Mesylate (E7389) in Patients With Advanced Non-small Cell Lung Cancer Previously Treated With a Taxane: A California Cancer Consortium Trial. 2012.